Posted on May 10, 20235/10/23
Navigating an Ever-evolving Canadian Market Access and Reimbursement Environment
Posted on May 9, 20235/9/23
From Limitations to Expansions: How Prioritizing Patients’ Speed to Therapy Drives Therapy Adoption
Posted on May 5, 20235/5/23
Case Study: Primary Research Meets Data-Driven Sources and Technology to Form Powerful Market Access Solutions
Posted on April 21, 20234/21/23
Left-Right-Left: The Latest in Pharma-Payer Ping Pong
Posted on April 20, 20234/20/23
Your Guide to Developing a Best-in-Class Specialty Pharmacy Network Strategy
Posted on April 18, 20234/18/23
Employ an Integrated Market Access Strategy to Deliver Brand Success
Posted on April 17, 20234/17/23
What EVERSANA’s Growing Abstract Count at ISPOR U.S. Means to the HEOR Industry
Posted on April 13, 20234/13/23
Peeking Behind the PBM-lead GPO Curtain
Posted on April 11, 20234/11/23
Elevating Field Reimbursement Manager Performance through Insights & Comparative Data
Posted on April 6, 20234/6/23